Clinical Trial Update: Novartis Vaccine and Diagnostics Carriage Trial [Phase 3]

View source ↗

Summary

Phase 3 trial by Novartis Vaccines evaluated the meningococcal conjugate vaccine for its effect on Neisseria meningitidis carriage; results were posted in Janua…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Neisseria Meningitidis Carriage

Drugs mentioned

• Menveo (meningococcal group A, C, W-135 and Y conjugate vaccine)

Snippet

Sponsor: Novartis Vaccines | Conditions: N. Meningitidis Carriage | Phase 3 | Status: COMPLETED | Results posted: 2014-01-23